Logo image of CAH

CARDINAL HEALTH INC (CAH) Stock Earnings & Estimates

USA - New York Stock Exchange - NYSE:CAH - US14149Y1082 - Common Stock

208.29 USD
+0.75 (+0.36%)
Last: 12/26/2025, 8:04:00 PM
208.29 USD
0 (0%)
After Hours: 12/26/2025, 8:04:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
CAH revenue by date.CAH revenue by date.
205.012B
13.04%
226.827B
10.64%
222.578B
-1.87%
259.52B
16.60%
280.945B
8.26%
299.126B
6.47%
330.195B
10.39%
352.653B
6.80%
EBITDA
YoY % growth
CAH ebitda by date.CAH ebitda by date.
2.466B
4.09%
2.86B
15.98%
3.273B
14.44%
3.957B
20.90%
4.326B
9.33%
4.715B
8.99%
N/AN/A
EBIT
YoY % growth
CAH ebit by date.CAH ebit by date.
1.774B
5.78%
2.15B
21.20%
2.483B
15.49%
3.403B
37.05%
3.743B
9.99%
4.087B
9.19%
4.459B
9.10%
4.715B
5.74%
Operating Margin
CAH operating margin by date.CAH operating margin by date.
0.87%0.95%1.12%1.31%1.33%1.37%1.35%1.34%
EPS
YoY % growth
CAH eps by date.CAH eps by date.
5.81
14.82%
7.47
28.57%
8.24
10.31%
9.93
20.46%
11.10
11.81%
12.37
11.44%
14.10
14.02%
15.21
7.87%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
2.31
19.81%
2.73
16.11%
2.31
11.21%
2.70
5.88%
2.66
14.95%
3.05
11.73%
2.59
11.85%
2.91
7.92%
2.83
6.40%
3.21
5.19%
2.86
10.67%
Revenue
Q2Q % growth
65.11B
17.82%
62.88B
14.58%
67.149B
11.62%
67.771B
5.88%
69.594B
6.89%
66.033B
5.01%
71.865B
7.02%
71.713B
5.82%
73.875B
6.15%
69.928B
5.90%
76.427B
6.35%
EBITDA
Q2Q % growth
909.85M
-3.21%
1.034B
-21.19%
911.09M
-35.79%
1.096B
9.16%
1.058B
16.28%
1.12B
8.32%
1.033B
13.38%
1.247B
13.78%
1.178B
11.34%
1.224B
9.29%
1.153B
11.62%
EBIT
Q2Q % growth
808.51M
42.85%
935.18M
27.93%
801.01M
27.35%
926.84M
20.21%
937.6M
15.97%
1.026B
9.71%
886.12M
10.63%
985.15M
6.29%
974.4M
3.92%
1.093B
6.53%
971.09M
9.59%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2026
Q2Q % growth
2.55
35.64%
2.200.3515.85%
Q4 2025
Q2Q % growth
2.08
13.04%
2.060.021.06%
Q3 2025
Q2Q % growth
2.35
12.98%
2.190.167.37%
Q2 2025
Q2Q % growth
1.93
6.04%
1.780.158.65%
Q1 2025
Q2Q % growth
1.88
8.67%
1.630.2515.13%
Q4 2024
Q2Q % growth
1.84
18.71%
1.760.084.62%
Q3 2024
Q2Q % growth
2.08
19.54%
1.970.115.55%
Q2 2024
Q2Q % growth
1.82
37.88%
1.620.2012.64%
Q1 2024
Q2Q % growth
1.73
44.17%
1.420.3121.95%
Q4 2023
Q2Q % growth
1.55
47.62%
1.510.042.66%
Q3 2023
Q2Q % growth
1.74
20.00%
1.500.2415.83%
Q2 2023
Q2Q % growth
1.32
3.94%
1.150.1714.85%
Q1 2023
Q2Q % growth
1.20
-6.98%
0.950.2526.10%
Q4 2022
Q2Q % growth
1.05
-19.23%
1.19-0.14-11.53%
Q3 2022
Q2Q % growth
1.45
-5.23%
1.54-0.09-5.87%
Q2 2022
Q2Q % growth
1.27
-27.01%
1.240.032.45%
Q1 2022
Q2Q % growth
1.29
-14.57%
1.34-0.05-3.68%
Q4 2021
Q2Q % growth
1.30
25.00%
1.210.097.29%
Q3 2021
Q2Q % growth
1.53
-5.56%
1.57-0.04-2.38%
Q2 2021
Q2Q % growth
1.74
14.47%
1.460.2819.40%
Q1 2021
Q2Q % growth
1.51
18.90%
1.140.3731.93%
Q4 2020
Q2Q % growth
1.04
-6.31%
0.930.1112.43%
Q3 2020
Q2Q % growth
1.62
1.89%
1.450.1711.94%
Q2 2020
Q2Q % growth
1.52
17.83%
1.230.2923.28%
Q1 2020
Q2Q % growth
1.27
-1.55%
1.110.1614.87%
Q4 2019
Q2Q % growth
1.11 0.940.1718.32%
Q3 2019
Q2Q % growth
1.59 1.440.1510.33%
Q2 2019
Q2Q % growth
1.29 1.100.1917.41%
Q1 2019
Q2Q % growth
1.29 1.090.2018.69%
CAH Yearly EPS VS EstimatesCAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2026
Q2Q % growth
64.009B
22.44%
59.789B4.22B7.06%
Q4 2025
Q2Q % growth
60.159B
0.49%
61.48B-1.321B-2.15%
Q3 2025
Q2Q % growth
54.878B
-0.06%
55.907B-1.029B-1.84%
Q2 2025
Q2Q % growth
55.264B
-3.80%
55.567B-303M-0.55%
Q1 2025
Q2Q % growth
52.277B
-4.54%
51.404B873M1.70%
Q4 2024
Q2Q % growth
59.867B
12.00%
59.285B582M0.98%
Q3 2024
Q2Q % growth
54.911B
8.76%
56.615B-1.704B-3.01%
Q2 2024
Q2Q % growth
57.445B
11.61%
57.583B-138M-0.24%
Q1 2024
Q2Q % growth
54.763B
10.40%
55.306B-543M-0.98%
Q4 2023
Q2Q % growth
53.453B
13.57%
53.246B207M0.39%
Q3 2023
Q2Q % growth
50.487B
12.60%
50.206B281M0.56%
Q2 2023
Q2Q % growth
51.469B
13.23%
51.251B218M0.43%
Q1 2023
Q2Q % growth
49.603B
12.82%
48.668B935M1.92%
Q4 2022
Q2Q % growth
47.065B
10.52%
45.161B1.904B4.22%
Q3 2022
Q2Q % growth
44.836B
14.16%
43.591B1.245B2.86%
Q2 2022
Q2Q % growth
45.457B
9.43%
46.028B-571M-1.24%
Q1 2022
Q2Q % growth
43.968B
12.55%
42.352B1.616B3.82%
Q4 2021
Q2Q % growth
42.586B
16.07%
40.828B1.758B4.31%
Q3 2021
Q2Q % growth
39.275B
0.30%
40.494B-1.219B-3.01%
Q2 2021
Q2Q % growth
41.541B
4.55%
41.852B-311M-0.74%
Q1 2021
Q2Q % growth
39.065B
4.62%
38.559B506M1.31%
Q4 2020
Q2Q % growth
36.689B
-1.78%
37.04B-351M-0.95%
Q3 2020
Q2Q % growth
39.157B
11.15%
37.316B1.841B4.93%
Q2 2020
Q2Q % growth
39.735B
5.29%
39.826B-91M-0.23%
Q1 2020
Q2Q % growth
37.341B
6.04%
37.115B226M0.61%
Q4 2019
Q2Q % growth
37.353B 37.183B170M0.46%
Q3 2019
Q2Q % growth
35.228B 35.547B-319M-0.90%
Q2 2019
Q2Q % growth
37.74B 36.46B1.28B3.51%
Q1 2019
Q2Q % growth
35.213B 33.991B1.222B3.60%
CAH Yearly Revenue VS EstimatesCAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100B 200B 300B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.07% 3.46% 2.08% 4.16%
Revenue0.6% 3.44% 1.16% 3.34%